We are live on ! Find out more
TMO icon

Thermo Fisher Scientific

2,365 hedge funds and large institutions have $173B invested in Thermo Fisher Scientific in 2023 Q3 according to their latest regulatory filings, with 142 funds opening new positions, 966 increasing their positions, 887 reducing their positions, and 135 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% more repeat investments, than reductions

Existing positions increased: 966 | Existing positions reduced: 887

5% more first-time investments, than exits

New positions opened: 142 | Existing positions closed: 135

0.89% less ownership

Funds ownership: 89.44%88.54% (-0.89%)

1% less funds holding

Funds holding: 2,3872,365 (-22)

2% less call options, than puts

Call options by funds: $1.23B | Put options by funds: $1.25B

3% less capital invested

Capital invested by funds: $178B → $173B (-$4.73B)

1% less funds holding in top 10

Funds holding in top 10: 141139 (-2)

Holders
2,365
Holders Change
-22
Holders Change %
-0.92%
% of All Funds
37.53%
Holding in Top 10
139
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-1.42%
% of All Funds
2.21%
New
142
Increased
966
Reduced
887
Closed
135
Calls
$1.23B
Puts
$1.25B
Net Calls
-$26.6M
Net Calls Change
+$128M
Name Holding Trade Value Shares
Change
Change in
Stake
CCMG
351
Clark Capital Management Group
Pennsylvania
$33M +$581K +1,090 +2%
CF
352
Covea Finance
France
$32.7M +$5.56M +10,430 +19%
NYLIM
353
New York Life Investment Management
New York
$32.4M -$480K -901 -1%
PGFC
354
Peapack-Gladstone Financial Corp
New Jersey
$32.4M +$1.05M +1,962 +3%
WA
355
WestEnd Advisors
North Carolina
$32.3M +$2.72M +5,111 +9%
BCM
356
Bowie Capital Management
Texas
$32.2M +$10.3M +19,373 +44%
OAM
357
Oppenheimer Asset Management
New York
$31.8M +$1.53M +2,876 +5%
EOJOAM
358
E. Ohman J:or Asset Management
Sweden
$31.7M -$1.13M -2,113 -3%
OIAM
359
OFI Invest Asset Management
France
$31.5M -$455K -854 -1%
PHS
360
PFM Health Sciences
California
$31.5M
DP
361
Dundas Partners
United Kingdom
$31.3M +$4.52M +8,477 +16%
SRC
362
Shufro Rose & Co
New York
$31.1M +$156K +292 +0.5%
GF
363
Gabelli Funds
New York
$30.9M -$6.25M -11,728 -16%
AAM
364
Aureus Asset Management
Massachusetts
$30.4M -$1.1M -2,070 -3%
FAF
365
Fjarde Ap-fonden
Sweden
$30.4M -$1.23M -2,300 -4%
ProShare Advisors
366
ProShare Advisors
Maryland
$30.2M -$1.77M -3,322 -5%
HFS
367
Hantz Financial Services
Michigan
$30.1M +$460K +864 +1%
Tudor Investment Corp
368
Tudor Investment Corp
Connecticut
$29.4M -$208K -391 -0.7%
Man Group
369
Man Group
United Kingdom
$29.2M -$36.4M -68,289 Closed
ASC
370
Atalanta Sosnoff Capital
New York
$29M -$31.3M -58,694 -51%
CCM
371
Cohen Capital Management
California
$28.7M
EDRH
372
Edmond de Rothschild Holding
Switzerland
$28.7M +$1.95M +3,653 +7%
PFPT
373
Pinnacle Financial Partners (Tennessee)
Tennessee
$28.7M -$313K -587 -1%
TAM
374
Thematics Asset Management
France
$28.5M -$11.4M -21,414 -28%
NMIFOAC
375
National Mutual Insurance Federation of Agricultural Cooperatives
Japan
$28.3M +$2.82M +5,300 +10%

TMO Hedge Fund Activity: Q3 2023 in Review

2,365 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q3 2023, worth a combined $173B — down 2.7% from $178B a quarter earlier.

Buyers outnumbered sellers: 142 funds opened new TMO positions and 135 closed out — a net gain of 7 holders — while 966 added to existing stakes and 887 trimmed.

The largest buyer was DZ Bank, adding an estimated $755M. The largest seller was Arthur M. Cohen & Associates, cutting an estimated $1.66B.

  • 2,365 institutional investors held Thermo Fisher Scientific (TMO) as of Q3 2023, down from 2,387 in Q2 2023.
  • Funds reported $173B of Thermo Fisher Scientific stock for Q3 2023, down 2.7% quarter-over-quarter.
  • 142 funds opened new Thermo Fisher Scientific positions in Q3 2023 and 135 closed out, a net change of +7 holders.
  • The largest Thermo Fisher Scientific buyer in Q3 2023 was DZ Bank, an estimated $755M added.
  • The largest Thermo Fisher Scientific seller in Q3 2023 was Arthur M. Cohen & Associates, an estimated $1.66B sold.

Based on aggregated 13F filings for Q3 2023.